|
|
|
Volumn 55, Issue 1, 2000, Pages 57-60
|
|
Telmisartan (Micardis®);Pharma-clinics. Le medicament du mois. Le telmisartan (Micardis®)
a
|
|
Author keywords
Angiotensin II AT1 receptor antagonist; Arterial hypertension; Insurmountable antagonism; Telmisartan
|
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CANDESARTAN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
HYDROCHLOROTHIAZIDE;
IRBESARTAN;
LISINOPRIL;
LOSARTAN;
PLACEBO;
TELMISARTAN;
ANGIOTENSIN RECEPTOR;
BENZIMIDAZOLE DERIVATIVE;
BENZOIC ACID DERIVATIVE;
ANTIHYPERTENSIVE THERAPY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
ESSENTIAL HYPERTENSION;
HUMAN;
HYPERTENSION;
MAJOR CLINICAL STUDY;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
REVIEW;
ARTICLE;
HALF LIFE TIME;
PHYSIOLOGY;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BENZIMIDAZOLES;
BENZOATES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HALF-LIFE;
HUMANS;
HYPERTENSION;
RECEPTORS, ANGIOTENSIN;
|
|
EID: 0033649283
PISSN: 00353663
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (6)
|
|
References (16)
|
